Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DBM-819

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
The effects of a newly synthesized ATPase inhibitor,1-(2-methyl-4-methoxypheny)-4-[(3-hy-droxypropyl)amino] -6-methyl-2,3… Expand
Is this relevant?
2002
2002
A high-performance liquid chromatographic (HPLC) method was developed for the determination of a new proton pump inhibitor, DBM… Expand
Is this relevant?
2001
2001
The dose-dependent pharmacokinetic parameters of DBM-819 were evaluated after intravenous (5, 10 and 20 mg/kg) and oral (10, 20… Expand
Is this relevant?
2001
2001
A new compound, 1-(2-methyl-4-methoxyphenyl)-4-[(3-hydroxypropyl)amino]-6-methyl-2,3-dihydropyrrolo[3,2-c]quinoline (DBM-819… Expand
Is this relevant?
2001
2001
A new compound, 1-(2-methyl-4-methoxyphenyl)-4-[(3-hydroxypropyl)amino]-6-methyl-2,3-dihydropyrrolo[3,2-c]quinoline (DBM-819… Expand
Is this relevant?
2001
2001
The metabolism of 1-(2-methyl-4-methoxyphenyl)-4-[(3-hydroxypropyl)amino]-6-methyl-2,3-dihydropyrrolo[3,2c]quinoline (DBM-819), a… Expand
Is this relevant?